Publications for Anna Ansell
Co-author map based on ISI articles 2007-

Keywords

tumor treatment squamous sensitivity resistance radiotherapy predictive neck lines hnscc head genes gene egfr cisplatin cetuximab cells carcinoma cancer cafs

Journal Articles

Lovisa Farnebo, Katharina Tiefenböck, Anna Ansell, Lena Thunell, Stina Garvin and Karin Roberg
  Strong expression of survivin is associated with positive response to radiotherapy and improved overall survival in head and neck squamous cell carcinoma patients
  International Journal of Cancer, 2013, 133(8), 1994-2003.
 Web of Science® Times Cited: 3

Adam Jedlinski, Anna Ansell, Ann-Charlotte Johansson and Karin Roberg
  EGFR status and EGFR ligand expression influence the treatment response of head and neck cancer cell lines
  Journal of Oral Pathology & Medicine, 2013, 42(1), 26-36.
 Web of Science® Times Cited: 3

Ann-Charlotte Johansson, Anna Ansell, Fredrik Jerhammar, Maja Bradic Lindh, Reidar Grenman, Eva Munck-Wikland, Arne Ostman and Karin Roberg
  Cancer-Associated Fibroblasts Induce Matrix Metalloproteinase-Mediated Cetuximab Resistance in Head and Neck Squamous Cell Carcinoma Cells
  Molecular Cancer Research, 2012, 10(9), 1158-1168.
 Web of Science® Times Cited: 8

Ola Wahlström, Cecilia Linder, Anna Ansell, Anders Kalén, Mats Söderström and Per Magnusson
  Acidic preparations of lysed platelets upregulate proliferative pathways in osteoblast-like cells as demonstrated by genome-wide microarray analysis
  Platelets, 2011, 22(6), 452-460.
   Fulltext  PDF  

Lovisa Farnebo, Adam Jedlinski, Anna Ansell, Linda Vainikka, Lena Thunell, Reidar Grenman, Ann-Charlotte Johansson and Karin Roberg
  Proteins and single nucleotide polymorphisms involved in apoptosis, growth control, and DNA repair predict cisplatin sensitivity in head and neck cancer cell lines
  International Journal of Molecular Medicine, 2009, 24(4), 549-556.
 Web of Science® Times Cited: 13

Anna Ansell, Fredrik Jerhammar, Rebecca Ceder, Roland Grafström, Reidar Grénman and Karin Roberg
  Matrix metalloproteinase-7 and -13 expression associate to cisplatin resistance in head and neck cancer cell lines.
  Oral Oncology, 2009, 45(10), 866-871.

Anna Ansell, Lovisa Farnebo, Reidar Grenman, Karin Roberg and Lena Thunell
  Polymorphism of FGFR4 in cancer development and sensitivity to cisplatin and radiation in head and neck cancer
  Oral Oncology, 2009, 45(1), 23-29.

Conference Articles

Ola Wahlström, Olof Risto, Anders Kalén, Cecilia Linder, Anna Ansell, Mats Söderström and Per Magnusson
  Acidic preparations of lysed platelets up-regulate proliferative and vascular genes, and the TGFBR pathway in osteoblast-like cells in BONE, vol 48, issue , pp S118-S118
  BONE, 2011.


A Johansson, Anna Ansell, A Ostman and Karin Roberg
  Cancer-associated fibroblasts desensitizes head and neck squamous cell carcinoma cells to epidermal growth factor receptor-targeted therapy in EJC SUPPLEMENTS, vol 8, issue 5, pp 134-134
  EJC SUPPLEMENTS, 2010.


Anna Ansell, Fredrik Jerhammar, R Ceder, R Grenman and Karin Roberg
  Matrix metalloproteinase-7 and-13 predict response to cisplatin in head and neck cancer in ORAL ONCOLOGY, vol , issue , pp 94-94
  ORAL ONCOLOGY, 2009.


Ph.D. Theses

Anna Ansell
  Identification of Tumor Cell- and Stroma Derived Biomarkers of Treatment Response in Head and Neck Cancer
  2013.


  Fulltext PDF